Description

▪ Introduction

Nandrophen by Proton Pharma contains Nandrolone Phenylpropionate 100 mg/mL, a short-acting injectable formulation studied in clinical and laboratory environments for its anabolic properties. It has been historically utilized under medical supervision to support red blood cell production and bone metabolism. Due to its shorter ester chain, this compound offers faster release, making it suitable for studies requiring more frequent dosing schedules.

Each unit is produced under pharmaceutical-grade conditions to ensure sterility, precision, and consistency for laboratory and analytical use.

▪ Product Details (Bulleted)

• Active Ingredient: Nandrolone Phenylpropionate

• Dosage Strength: 100 mg/mL

• Form: Injectable oil-based solution (intramuscular)

• Brand: Proton Pharma

• Package Size: 10 × 1 mL ampoules

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Nandrolone Phenylpropionate has an approximate half-life of 2–4 days. The phenylpropionate ester allows for faster absorption and clearance than longer esters, requiring administration every 2–3 days to maintain consistent plasma levels in experimental settings. It does not significantly aromatize, making it suitable for androgen receptor-focused studies.

▪ Usage Recommendations

• Typical Experimental Dosage: 50–100 mg every 2–3 days depending on research protocol

• Administration Route: Intramuscular injection using aseptic technique

• Use Statement: For laboratory and analytical research purposes only

▪ Disclaimer

This product is intended strictly for laboratory and analytical use. It is not approved for human consumption or therapeutic application. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with underlying health conditions. All use must comply with institutional guidelines and applicable local regulations.